SXTPEarnings•globenewswire•
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results
Sentiment:Negative (30)
Summary
60 Degrees Pharma (Nasdaq: SXTP) Q2 2025: Supply issue cut revenue, profits rose from cash-pay sales; $1.97M cash extends runway to Mar 2026.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 13, 2025 by globenewswire